The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

Across biomedical research and drug development, the boundaries of possibility are shifting. To meet these challenges, the field increasingly depends on affinity ligands capable of unlocking targets ...

UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...

In the PIV Notice, WhiteOak alleges that the claims of 19 EXPAREL patents listed in the FDA’s Orange Book (U.S. Patent Nos.11 ...

Shares of Pacira BioSciences fell after the company said it plans to defend its intellectual property against The WhiteOak Group, which has filed an abbreviated new drug application seeking approval ...

Pacira BioSciences (PCRX) stock drops as the firm says a U.S. marketing application has been filed for a generic drug ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

In the competitive world of small-cap biotechnology, CorMedix CRMD and Theravance Biopharma TBPH stand out as two companies ...

Lady Purple was awarded Gold during the latest Pure Beauty Awards 2025 as the Best New Ingredient. This article dives deep ...

Google has announced that it has achieved the first verifiable quantum advantage, running an algorithm 13,000 times faster ...

As business leaders worldwide focus on re-energizing workforces after years of upheaval, Kevin Guest, Executive Chairman of USANA Health Sciences , is urging CEOs to lead with renewed authenticity, ...

In a pop-up city off the coast of Honduras, longevity startups are trying to fast-track anti-aging drugs. Is this the future ...